James Hippel Bio Techne Corp (TECH) insider trading activity

James Hippel is CFO of BIO-TECHNE Corp. Currently has a direct ownership of 106,610 shares of TECH, which is worth approximately $7.33 Million. The most recent transaction as insider was on Nov 01, 2024, when has been sold 6,475 shares (Common Stock) at a price of $75.31 per share, resulting in proceeds of $487,632. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 107K

6.69% 3M change

85.21% 12M change

Total Value Held $7.33 Million

James Hippel Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 01 2024	SELL Payment of exercise price or tax liability	$487,632 $75.31 p/Share	6,475 Reduced 5.73%	106,610 Common Stock
Nov 01 2024	BUY Exercise of conversion of derivative security	-	13,159 Added 10.42%	113,085 Common Stock
Aug 02 2024	SELL Payment of exercise price or tax liability	$2,970,858 $82.35 p/Share	36,076 Reduced 26.53%	99,926 Common Stock
Aug 02 2024	BUY Exercise of conversion of derivative security	$1,656,780 $31.26 p/Share	53,000 Added 28.04%	136,002 Common Stock
Jul 23 2024	SELL Payment of exercise price or tax liability	$1,888,411 $77.77 p/Share	24,282 Reduced 22.63%	83,002 Common Stock
Jul 23 2024	BUY Exercise of conversion of derivative security	$1,094,100 $31.26 p/Share	35,000 Added 24.6%	107,284 Common Stock
Dec 19 2023	SELL Payment of exercise price or tax liability	$2,552,227 $77.42 p/Share	32,966 Reduced 31.44%	71,884 Common Stock
Dec 19 2023	BUY Exercise of conversion of derivative security	$1,478,254 $31.26 p/Share	47,289 Added 31.08%	104,850 Common Stock
Aug 05 2023	SELL Payment of exercise price or tax liability	$520,546 $82.17 p/Share	6,335 Reduced 9.91%	57,561 Common Stock
Aug 05 2023	BUY Exercise of conversion of derivative security	-	12,876 Added 16.77%	63,896 Common Stock
Aug 07 2022	SELL Payment of exercise price or tax liability	$742,196 $382.97 p/Share	1,938 Reduced 13.19%	12,755 Common Stock
Aug 07 2022	BUY Exercise of conversion of derivative security	-	3,938 Added 21.14%	14,693 Common Stock
Nov 02 2021	SELL Open market or private sale	$105,020 $525.1 p/Share	200 Reduced 1.83%	10,755 Common Stock
Nov 02 2021	BUY Exercise of conversion of derivative security	$25,010 $125.05 p/Share	200 Added 1.79%	10,955 Common Stock
Nov 01 2021	SELL Open market or private sale	$4,649,547 $527.04 p/Share	8,822 Reduced 45.06%	10,755 Common Stock
Nov 01 2021	BUY Exercise of conversion of derivative security	$1,103,191 $125.05 p/Share	8,822 Added 31.06%	19,577 Common Stock
Oct 29 2021	SELL Open market or private sale	$347,702 $525.23 p/Share	662 Reduced 5.8%	10,755 Common Stock
Oct 29 2021	BUY Exercise of conversion of derivative security	$82,783 $125.05 p/Share	662 Added 5.48%	11,417 Common Stock
Oct 28 2021	SELL Open market or private sale	$52,518 $525.18 p/Share	100 Reduced 0.92%	10,755 Common Stock
Sep 02 2021	SELL Open market or private sale	$5,082,000 $508.2 p/Share	10,000 Reduced 47.95%	10,855 Common Stock
Sep 02 2021	BUY Exercise of conversion of derivative security	$1,065,900 $106.59 p/Share	10,000 Added 32.41%	20,855 Common Stock
Aug 09 2021	SELL Open market or private sale	$4,809,700 $480.97 p/Share	10,000 Reduced 47.95%	10,855 Common Stock
Aug 09 2021	BUY Exercise of conversion of derivative security	$1,065,900 $106.59 p/Share	10,000 Added 32.41%	20,855 Common Stock
Aug 08 2021	SELL Payment of exercise price or tax liability	$802,230 $481.82 p/Share	1,665 Reduced 13.3%	10,855 Common Stock
Aug 08 2021	BUY Exercise of conversion of derivative security	-	3,383 Added 21.27%	12,520 Common Stock

James Hippel

CFO

Minneapolis, MN

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TECH shares.

Notify only if

Value

Insider Trading

Get notified when an Bio Techne Corp insider buys or sells TECH shares.

Notify only if

Operation

Value

Type

News

Receive news related to BIO-TECHNE Corp

Track Activities on TECH

Account